iRhythm Technologies Inc
NASDAQ:IRTC

Watchlist Manager
iRhythm Technologies Inc Logo
iRhythm Technologies Inc
NASDAQ:IRTC
Watchlist
Price: 122.35 USD 0.73% Market Closed
Market Cap: $4B

iRhythm Technologies Inc
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

iRhythm Technologies Inc
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
iRhythm Technologies Inc
NASDAQ:IRTC
Cash from Operating Activities
$80.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Cash from Operating Activities
$4.5B
CAGR 3-Years
44%
CAGR 5-Years
25%
CAGR 10-Years
21%
Edwards Lifesciences Corp
NYSE:EW
Cash from Operating Activities
$1.6B
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
11%
Stryker Corp
NYSE:SYK
Cash from Operating Activities
$5B
CAGR 3-Years
24%
CAGR 5-Years
9%
CAGR 10-Years
18%
Abbott Laboratories
NYSE:ABT
Cash from Operating Activities
$9.6B
CAGR 3-Years
3%
CAGR 5-Years
-1%
CAGR 10-Years
13%
Intuitive Surgical Inc
NASDAQ:ISRG
Cash from Operating Activities
$3B
CAGR 3-Years
27%
CAGR 5-Years
15%
CAGR 10-Years
14%
No Stocks Found

iRhythm Technologies Inc
Glance View

Market Cap
4B USD
Industry
Health Care

In the bustling realm of healthcare technology, where innovation meets necessity, iRhythm Technologies Inc. stands as a pivotal player, translating sophisticated algorithms into tangible, life-saving insights. Founded with the mission to redefine how cardiac care is delivered, iRhythm has pioneered its niche through the Zio platform—a sophisticated, wearable patch that monitors heart rhythms with precision. The Zio's elegant design belies its robust function, offering patients the comfort of continuous monitoring while living their daily lives. It gleans crucial data that is then transmitted to iRhythm's cloud-based platform, where advanced data analytics work tirelessly to think like a seasoned cardiologist, initially parsing through millions of heartbeats to identity potential abnormalities. As healthcare systems worldwide grapple with increasing demands and complexities, iRhythm's business model resonates well with the need for efficiency and effectiveness. The company generates revenue primarily through its patient-centric monitoring services, catering to healthcare providers who seek reliable diagnostic solutions. By billing insurers and healthcare institutions for the analytic results derived from the Zio patch, iRhythm seamlessly integrates into the cardiac care continuum. The blend of cutting-edge technology and strategic partnerships with healthcare providers not only fuels iRhythm's growth but also underscores a broader shift towards personalized and preventive medicine in cardiac care, demonstrating how strategic foresight can align with technical innovation to meet pressing healthcare challenges.

IRTC Intrinsic Value
68.56 USD
Overvaluation 44%
Intrinsic Value
Price $122.35

See Also

What is iRhythm Technologies Inc's Cash from Operating Activities?
Cash from Operating Activities
80.9m USD

Based on the financial report for Dec 31, 2025, iRhythm Technologies Inc's Cash from Operating Activities amounts to 80.9m USD.

What is iRhythm Technologies Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 1Y
2 285%

Over the last year, the Cash from Operating Activities growth was 2 285%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett